大麻素受体1在缺氧性肺动脉高压中调控肺动脉内皮间充质转化的作用及机制

基本信息
批准号:81700056
项目类别:青年科学基金项目
资助金额:20.00
负责人:宋莎莎
学科分类:
依托单位:大连医科大学
批准年份:2017
结题年份:2020
起止时间:2018-01-01 - 2020-12-31
项目状态: 已结题
项目参与者:齐艳,陈大朋,沈婷婷,赵雪融,李月,杨悦悦
关键词:
肺血管重构大麻素受体1肺动脉高压内质网应激内皮间充质转化
结项摘要

Pulmonary artery hypertension (PAH) is a malignant progressive disease, whose pathological process includes pulmonary vascular contraction and remodeling. Hypoxia-induced endothelial mesenchymal transition (EndMT) is a key factor in pulmonary artery remodeling, but the molecular mechanism of EndMT is unclear. We found that hypoxia up-regulated cannobinoid receptor 1(CB1) expression in pulmonary artery endothelium. Moreover, blocking CB1 inhibited not only the hypoxia-induced EndMT but also the activation of ATF-6, which was one signaling pathway of endoplasmic reticulum stress. Additionally, ATF-6 regulated the hypoxia-induced EndMT in pulmonary artery endothelial cells. Thus, we believe that hypoxia-up-regulated CB1 promotes pulmonary artery EndMT by activating endoplasmic reticulum stress. It will be proved by three studies, which are (1) clarifying the effect of CB1 on hypoxic pulmonary artery EndMT; (2) revealing the role of endoplasmic reticulum stress in CB1-regulated EndMT, and clarifying the molecular mechanism in CB1-regulated EndMT; (3) studying on the treatment of hypoxic PAH based on the key molecule and potential intervention target found in the molecular mechanism that CB1 regulates EndMT. This application will first explore the role of CB1 in hypoxic pulmonary artery EndMT. Moreover, revealing the molecular mechanism of EndMT regulated by CB1 will provide new drug targets and ideas for the PAH prevention and treatment.

肺动脉高压(PAH)是一种恶性进行性疾病,病理过程包括肺血管收缩和重构,缺氧诱导内皮间充质转化(EndMT)是血管重构的关键因素,分子机制尚不明确。我们发现缺氧上调肺动脉内皮中大麻素受体1(CB1)表达,阻断CB1可抑制缺氧诱导的EndMT并抑制内质网应激ATF-6通路激活;在细胞水平,ATF-6介导了缺氧诱导的EndMT。因而,我们认为缺氧上调的CB1通过激活内质网应激促进肺动脉EndMT。拟通过下述研究证明该假设:(1)阐明CB1对缺氧性肺血管EndMT的作用;(2)揭示内质网应激在CB1调控EndMT中的作用,阐明CB1调控EndMT的分子机制;(3)基于CB1调控EndMT分子机制的关键分子和潜在干预靶点治疗缺氧所致PAH的探索。本申请将首次探索CB1在缺氧性肺血管EndMT中的作用;揭示CB1调控EndMT的分子机制为肺动脉高压预防和治疗提供新的药物靶点和思路。

项目摘要

肺动脉高压(PAH)是一种恶性进行性疾病,病理过程包括肺血管收缩和重构,缺氧诱导内皮间充质转化(EndMT)是血管重构的关键因素,分子机制尚不明确。我们发现缺氧上调肺动脉内皮中大麻素受体1(CNR1)表达,阻断CNR1可抑制缺氧诱导的EndMT并抑制内质网应激ATF-6通路激活;缺氧通过转录因子HIF-1α结合CNR1启动子区,促进CNR1转录增加;CNR1通过激活内质网应激信号通路ATF-6,ATF-6通过转录因子EHF结合CDH5启动子区抑制CDH5的表达,从而促进肺动脉内皮EndMT。因而,缺氧通过HIF-1α上调的CNR1的表达,CNR1激活内质网应激关键蛋白ATF-6,进而促进转录因子EHF与CDH5启动子区结合抑制CDH5的表达诱导肺动脉EndMT。本研究首次探索CNR1在缺氧性肺血管EndMT中的作用,揭示CNR1调控EndMT的分子机制为肺动脉高压预防和治疗提供新的药物靶点和思路。

项目成果
{{index+1}}

{{i.achievement_title}}

{{i.achievement_title}}

DOI:{{i.doi}}
发表时间:{{i.publish_year}}

暂无此项成果

数据更新时间:2023-05-31

其他相关文献

1

基于一维TiO2纳米管阵列薄膜的β伏特效应研究

基于一维TiO2纳米管阵列薄膜的β伏特效应研究

DOI:10.7498/aps.67.20171903
发表时间:2018
2

DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素

DeoR家族转录因子PsrB调控黏质沙雷氏菌合成灵菌红素

DOI:10.3969/j.issn.1673-1689.2021.10.004
发表时间:2021
3

Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x

Intensive photocatalytic activity enhancement of Bi5O7I via coupling with band structure and content adjustable BiOBrxI1-x

DOI:10.1016/j.scib.2017.12.016
发表时间:2018
4

Asymmetric Synthesis of (S)-14-Methyl-1-octadecene, the Sex Pheromone of the Peach Leafminer Moth

Asymmetric Synthesis of (S)-14-Methyl-1-octadecene, the Sex Pheromone of the Peach Leafminer Moth

DOI:
发表时间:
5

七羟基异黄酮通过 Id1 影响结直肠癌细胞增殖

七羟基异黄酮通过 Id1 影响结直肠癌细胞增殖

DOI:
发表时间:

宋莎莎的其他基金

相似国自然基金

1

内皮-间充质转化参与低氧性肺动脉高压发生及其相关机制研究

批准号:81000017
批准年份:2010
负责人:张博
学科分类:H0107
资助金额:20.00
项目类别:青年科学基金项目
2

内皮源性GAPDH在缺氧性肺动脉高压血管重构中的作用及机制

批准号:81700055
批准年份:2017
负责人:谭如彬
学科分类:H0107
资助金额:20.00
项目类别:青年科学基金项目
3

内皮-间充质转化在A2aR基因敲除小鼠肺动脉高压形成中的作用及积雪草苷的干预研究

批准号:81470250
批准年份:2014
负责人:王良兴
学科分类:H0107
资助金额:75.00
项目类别:面上项目
4

FGF-2通过β-连环蛋白-LEF-1调控CTEPH肺动脉内皮间充质转化中的作用及机制

批准号:81770367
批准年份:2017
负责人:邓朝胜
学科分类:H0206
资助金额:55.00
项目类别:面上项目